4.0 Review

Treatment of difficult-to-treat depression - clinical guideline for selected interventions

Journal

NORDIC JOURNAL OF PSYCHIATRY
Volume 76, Issue 3, Pages 177-188

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/08039488.2021.1952303

Keywords

Clinical guideline; treatment-resistant depression; refractory depression; persistent depressive disorder; affective disorders

Categories

Funding

  1. National Health Authority, Denmark

Ask authors/readers for more resources

The study formulated an evidence-based guideline for difficult-to-treat depression in Denmark, finding weak evidence to support repetitive transcranial magnetic stimulation (rTMS) and cognitive behavioural analysis system of psychotherapy (CBASP) as interventions, but insufficient evidence for other interventions such as intravenous ketamine/esketamine, rumination-focused psychotherapy, or cognitive remediation.
Background Difficult-to-treat-depression (DTD) is a clinical challenge. The interventions that are well-established for DTD are not suitable or effective for all the patients. Therefore, more treatment options are highly warranted. We formulated an evidence-based guideline concerning six interventions not well-established for DTD in Denmark. Methods Selected review questions were formulated according to the PICO principle with specific definitions of the patient population (P), the intervention (I), the comparison (C), and the outcomes of interest (O), and systematic literature searches were performed stepwise for each review question to identify relevant systematic reviews/meta-analyses, and randomized controlled trials. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the methodological quality of the included studies. Clinical recommendations were formulated based on the evidence, the risk-benefit ratio, and perceived patient preferences. Results We found sufficient evidence for a weak recommendation of repetitive transcranial magnetic stimulation (rTMS) and cognitive behavioural analysis system of psychotherapy (CBASP). The use of bright light therapy in DTD was not sufficiently supported by the evidence, but should be considered as good clinical practice. The interventions should be considered in addition to ongoing antidepressant treatment. We did not find sufficient evidence to recommend intravenous ketamine/esketamine, rumination-focused psychotherapy, or cognitive remediation to patients with DTD. Conclusion The evidence supported two of the six reviewed interventions, however it was generally weak which emphasizes the need for more good quality studies. This guideline does not cover all treatment options and should be regarded as a supplement to relevant DTD-guidelines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available